title: Acute purulent pericarditis following staged percutaneous coronary intervention for multivessel disease.
authors: Department of Cardiology, Affiliated Shantou Hospital of Sun Yat-sen University, 114 Waima Road, Jinping District, 515031, Shantou, Guangdong, PR China.
authors: Y
authors: Y
authors: Li
authors: R
authors: R
authors: Xu
authors: Z
authors: Z
authors: Cai
authors: G
authors: G
authors: Ma
authors: L
authors: L
authors: Wang
authors: P
authors: P
authors: Chen
authors: Z
authors: Z
authors: Zhu
mesh_terms: D000208:Acute Disease; D000368:Aged; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002438:Cefoperazone / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003324:Coronary Artery Disease / Q000150:complications / Q000175:diagnosis / Q000601:surgery*; D004322:Drainage; D004338:Drug Combinations; D005260:Female; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects*; D010493:Pericarditis / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy*; D011552:Pseudomonas Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology*; D011550:Pseudomonas aeruginosa; D013407:Sulbactam / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D002438:Cefoperazone; C057923:sulperazone; D013407:Sulbactam